IO Biotech
Marion Chapellier is a Senior Scientist at IO Biotech, specializing in the preclinical development of immunotherapies for cancer treatment since November 2019. Responsibilities include leading preclinical research projects, coordinating with external collaborators and CROs, and performing data analysis and report writing for diverse audiences. Techniques employed encompass murine syngenic tumor models, in vivo studies, and multicolor flow cytometry. Previous experience includes roles as a Research Scientist at Lund University and a Postdoctoral Research Scientist at INSERM U1052 CNRS, focusing on anti-leukemic compounds and breast cancer research. Education includes a PhD in Oncology and Cancer Biology, a Master's degree in Genetics and Cell Biology, and a Bachelor's degree in Biology from Université Claude Bernard Lyon 1.
IO Biotech
2 followers
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Their pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules.